Scholars@Duke publication: Cardiac-specific ablation of GRK2 re-defines its roles in heart development and beta-adrenergic signaling

Cardiac-specific ablation of GRK2 re-defines its roles in heart development and beta-adrenergic signaling

Publication , Conference

Matkovich, SJ; Marreez, Y; Diwan, A; Odley, AM; Koch, WJ; Schwartz, RJ; Brunskill, EW; Dorn, GW

Published in: CIRCULATION

2006

CIRCULATION

1524-4539

0009-7322

2006

114

159 / 159

APA

Chicago

ICMJE

MLA

NLM

Matkovich, S. J., Marreez, Y., Diwan, A., Odley, A. M., Koch, W. J., Schwartz, R. J., … Dorn, G. W. (2006). Cardiac-specific ablation of GRK2 re-defines its roles in heart development and beta-adrenergic signaling. In CIRCULATION (Vol. 114, pp. 159–159).

Matkovich, Scot J., Yehia Marreez, Abhinav Diwan, Amy M. Odley, Walter J. Koch, Robert J. Schwartz, Eric W. Brunskill, and Gerald W. Dorn. “Cardiac-specific ablation of GRK2 re-defines its roles in heart development and beta-adrenergic signaling.” In CIRCULATION, 114:159–159, 2006.

Matkovich SJ, Marreez Y, Diwan A, Odley AM, Koch WJ, Schwartz RJ, et al. Cardiac-specific ablation of GRK2 re-defines its roles in heart development and beta-adrenergic signaling. In: CIRCULATION. 2006. p. 159–159.

Matkovich SJ, Marreez Y, Diwan A, Odley AM, Koch WJ, Schwartz RJ, Brunskill EW, Dorn GW. Cardiac-specific ablation of GRK2 re-defines its roles in heart development and beta-adrenergic signaling. CIRCULATION. 2006. p. 159–159.

CIRCULATION

1524-4539

0009-7322

2006

114

159 / 159